Drugs · acquisition-cost intelligence
Lidocaine
1% LIDOCAINE HCI· ingredient lidocaineAnalgesics and anesthetics· EPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.09024
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 8 weeks.
2025-02-012026-05-20
Same-ingredient options by acquisition cost
Other lidocaine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Burn Relief | $0.02792 | −$0.06230 |
| ALCEMISTE | $0.05101 | −$0.03920 |
| Lidocaine Viscous | $0.07984 | −$0.01040 |
| lidocaine | $0.15755 | +$0.06730 |
| Cadira Compliant Blood Stat | $0.21848 | +$0.12820 |
| LIDOCAINE HCl | $0.24343 | +$0.15320 |
| Lidocaine | $0.35160 | +$0.26140 |
| Acolye Numbing Cream Anorectal(Hemorrhoidal) Cream | $0.35967 | +$0.26940 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.